Glatopa Injection, Solution
Product Images NDC 63629-8815

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Glatopa (NDC 63629-8815). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure_01 (Glatopa Image 01)

A Kaplan-Meier curve graph depicting the percentage of second exacerbation over time up to 1080 days for Glatiramer Acetate Injection 20 mg/mL versus placebo. The graph shows cumulative incidence, with Glatiramer Acetate having a lower rate increase compared to placebo. The x-axis shows days, and the y-axis shows second exacerbation percentage. Sample sizes at various time points for both groups are listed below the x-axis.*

FDA Label Image

Figure_02 (Glatopa Image 02)

A line graph displaying the cumulative median number of enhancing lesions over nine months, comparing Glatiramer Acetate Injection and placebo. The x-axis represents time in months, and the y-axis shows the cumulative number of enhancing lesions. Two lines indicate lesion progression for each group, with Glatiramer Acetate Injection showing a lower curve than placebo over time.*

FDA Label Image

Figure_a (Glatopa Image 03)

An instructional illustration showing a sharps disposal container labeled with a biohazard symbol, a syringe in blister packaging, cotton balls, alcohol wipes, and an injection diary. These items are typically used for administering injections, likely related to the Glatopa (glatiramer acetate) injection product.*

FDA Label Image

Figure_a (Glatopa Image 04)

An instructional black-and-white illustration showing a person holding a syringe vial with both hands, preparing for subcutaneous injection. The image focuses on the hands and syringe vial, demonstrating the proper handling technique.*

FDA Label Image

Figure_c_abdomen (Glatopa Image 05)

An instructional diagram showing the human torso and abdomen with a marked injection site located on the lower abdomen area. The illustration is designed to guide the proper subcutaneous injection site for the medication.*

FDA Label Image

Figure_c_hips_and_arms (Glatopa Image 06)

Illustration showing the back view of a person highlighting recommended injection sites for subcutaneous administration on the outer upper arms and the lower back or abdomen area. The shaded areas indicate acceptable locations for glatiramer acetate injections.*

FDA Label Image

Figure_c_arms (Glatopa Image 07)

An anatomical illustration showing a person administering a subcutaneous injection in the upper arm, highlighting the injection site.*

FDA Label Image

Figure_c_thighs (Glatopa Image 08)

An anatomical illustration showing the recommended subcutaneous injection sites on the upper outer areas of both thighs. The shaded regions highlight the preferred injection zones for administering medication injection subcutaneously.*

FDA Label Image

Figure_d (Glatopa Image 09)

An instructional illustration showing a hand holding a syringe poised for subcutaneous injection. The image depicts the proper technique for injecting Glatopa (glatiramer acetate) solution under the skin, emphasizing correct hand positioning to facilitate administration.*

FDA Label Image

Figure_e (Glatopa Image 10)

An instructional diagram showing three steps for using a prefilled syringe. Each frame depicts a hand holding the syringe, demonstrating preparation and administration techniques for a subcutaneous injection.*

FDA Label Image

Figure_f (Glatopa Image 11)

An instructional illustration showing a hand pinching the skin at an injection site, typically used to demonstrate correct technique for subcutaneous injection administration.*

FDA Label Image

Figure_g (Glatopa Image 12)

An instructional illustration showing a hand holding a syringe and injecting a solution subcutaneously into the skin of an arm, demonstrating proper injection technique for a subcutaneous medication.*

FDA Label Image

Figure_h (Glatopa Image 13)

An instructional illustration showing hands preparing for a subcutaneous injection in the thigh area, with one hand holding a syringe and the other pressing on the skin. This visual is consistent with administration guidance for Glatopa (Glatiramer Acetate) injection.*

FDA Label Image

Figure_i (Glatopa Image 14)

An instructional black-and-white line drawing showing a hand holding a syringe poised for subcutaneous injection into the skin of the opposite arm. A small arrow indicates the injection site on the skin surface.*

FDA Label Image

Figure_j (Glatopa Image 15)

Illustration showing a hand holding a syringe, demonstrating the subcutaneous injection technique into an arm. The image depicts the proper angle and placement of the injection for a Glatopa (glatiramer acetate) subcutaneous injection, solution.*

FDA Label Image

Figure_k (Glatopa Image 16)

An instructional illustration showing a hand holding a syringe poised for subcutaneous injection into the upper arm or thigh. The image demonstrates proper needle insertion technique associated with administering an injectable medication such as Glatopa (glatiramer acetate) 20 mg/mL.*

FDA Label Image

Figure_l (Glatopa Image 17)

An illustration of a sharps disposal container featuring a biohazard symbol on its front. The container is designed for safe disposal of needles and other sharp medical waste.*

FDA Label Image

Label (Lbl636298815)

Label for Glatopa (glatiramer acetate injection) 20 mg/mL solution for subcutaneous injection by Bryant Ranch Prepack. The label includes dosing unit information that each pre-filled syringe contains 1 mL of 20 mg glatiramer acetate with mannitol as an inactive ingredient. The package contains 30 single-dose pre-filled syringes. Storage instructions advise refrigeration at 2° to 8°C and protection from light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.